Abstract We conducted a disproportionality analysis of the FDA Adverse Event Reporting System (FAERS) database (2005 Q22024 Q3) to evaluate neurological adverse events (NAEs) associated with six glucagon-like peptide-1 receptor agonists (GLP-1 RAs): exenatide, liraglutide, lixisenatide, dulaglutide, semaglutide, and tirzepatide
Semaglutide should be stored in a refrigerator between 36F to 46F (2C to 8C) until the expiration date
doi:10.2165/00002512-199812030-00006
The goal is to balance effectiveness with fewer side effects and potentially lower costs for those without insurance coverage
Peptide therapy is a treatment that encourages improved health and wellness using short chains of amino acids
Despite lofty claims that weight loss drugs will help mitigate medical costs related to obesitya medical designation still determined by BMI, which the American Medical Association has outright stated is racistthere is no evidence (yet) to support this claim, and, in fact, the drugs may have no impact at all on obesity-related medical costs (at least after two years of study)